WCMNY
IMMU

Westchester Capital Management (New York)’s Immunomedics Inc IMMU Stock Holding History

Westchester Capital Management (New York)’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-681,510
Closed -$57.9M – 297
2020
Q3 		$57.9M Buy
+681,510
New +$34.5M 2.44% 14

Westchester Capital Management (New York)'s IMMU Position: Q4 2020 in Review

Westchester Capital Management (New York) sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 681,510 shares — an estimated $57.9M sold.

Westchester Capital Management (New York) first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $57.9M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Westchester Capital Management (New York) reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 681,510 Immunomedics Inc shares in Q4 2020, an estimated $57.9M.
  • Westchester Capital Management (New York) first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
  • Westchester Capital Management (New York)'s Immunomedics Inc position peaked at $57.9M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2020, filed 12 Feb 2021.